Imhoff John E bought GTHP
September 30, 2026 · Form 4 insider transaction
Imhoff John E bought 1,650,215 shares of Guided Therapeutics, Inc. at $0.07 per share, a transaction worth $115.5K. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4.
Footnotes
On September 30, 2026, Dr. Imhoff converted $115,515.07 outstanding under a September 25, 2025 Convertible Promissory Note, consisting of $110,000 of principal and $5,515.07 of accrued interest, into 1,650,215 shares of common stock at a conversion price of $0.07 per share. The note was convertible at the holder's election upon nonpayment of a scheduled monthly installment of $10,000 plus accrued interest, payable beginning November 30, 2025. By mutual agreement with the Company, the amount converted included $60,000 of deferred installments due April through September 2026 and $50,000 of installments scheduled for October 2026 through February 2027. Following the conversion, the note has been paid in full.